{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/coeliac-disease/diagnosis/assessment/","result":{"pageContext":{"chapter":{"id":"d056d742-1aa4-57bc-8e9b-3730a715a6dd","slug":"assessment","fullItemName":"Assessment","depth":2,"htmlHeader":"<!-- begin field 062fac0b-509c-4fc2-920d-aba800e74639 --><h2>How should I assess a person with suspected coeliac disease?</h2><!-- end field 062fac0b-509c-4fc2-920d-aba800e74639 -->","summary":"","htmlStringContent":"<!-- begin item 5149f06f-1023-431d-b1e5-aba800e745dd --><!-- begin field 6f96ae44-16b3-41c4-a47f-aba800e74639 --><p><strong>If a person has a <strong><a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/diagnosis/diagnosis/\">suspected</a></strong> diagnosis of coeliac disease:</strong></p><ul><li><strong>Ask about:</strong><ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/diagnosis/diagnosis/\">Symptoms</a> of malabsorption, such as diarrhoea, steatorrhoea, weight loss; unexplained acid reflux; abdominal pain; bloating; constipation; and fatigue.</li><li>Any <a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/background-information/causes/\">family history</a> of coeliac disease.</li><li>Any <a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/background-information/causes/\">risk factors</a> for coeliac disease.</li><li>Any clinical features of <a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/background-information/complications/\">complications</a>.</li><li>Any associated conditions, such as type 1 diabetes mellitus or autoimmune thyroid disease.</li></ul></li><li><strong>Examine the person:</strong><ul><li>Check the height and weight, and calculate the body mass index (BMI).</li><li>Assess the abdomen for pain or distention.</li><li>Assess the skin for clinical features of <a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/diagnosis/diagnosis/\">dermatitis herpetiformis</a>.<ul><li>Note: fewer than 10% of people with dermatitis herpetiformis have symptoms or signs of malabsorption.</li></ul></li></ul></li><li><strong>Arrange coeliac serology testing.</strong><ul><li>Ensure that the person has eaten gluten-containing foods (with wheat, barley, or rye as an ingredient) in more than one meal a day, for a minimum of 6 weeks, <em>before</em> testing is performed.</li><li>Check the serum immunoglobulin (Ig)A tissue transglutaminase antibody (tTGA) and total IgA first-line.<ul><li>Explain that this test does not diagnose coeliac disease, but indicates whether further gastroenterology assessment is needed.</li><li>Check serum IgA endomysial antibody (EMA) second-line, if IgA tTGA testing is unavailable, or in cases where the result is weakly positive.</li><li>Consider checking serum IgG EMA, IgG deamidated gliadin peptide (DGP), or IgG tTGA if there is evidence of IgA deficiency.</li><li>Note: do <em>not</em> perform human leukocyte antigen (HLA) genetic testing in primary care to diagnose coeliac disease.</li></ul></li><li>Consider re-testing if a person presents with new symptoms of coeliac disease, despite previous negative serology.</li></ul></li><li><strong>Arrange referral to a gastroenterologist,</strong> the urgency depending on clinical judgement, for specialist endoscopic intestinal biopsy to confirm or exclude the diagnosis, if serology results suggest a diagnosis of coeliac disease. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/coeliac-disease/diagnosis/assessment/#interpreting-serology-results\">Interpreting serology results</a> for more information.<ul><li>Advise the person that they should continue to eat gluten-containing foods in more than one meal a day until specialist tests have been completed, even if serology is positive.</li><li>Explain that the diagnosis is confirmed if there are characteristic changes on histology of the small intestinal mucosa following biopsy.</li><li>Note: if a diagnosis of coeliac disease is strongly suspected, arrange referral for consideration of specialist tests even if serology is negative.</li></ul></li><li><strong>Arrange referral to a dermatologist if a diagnosis of dermatitis herpetiformis is suspected.</strong></li></ul><!-- end field 6f96ae44-16b3-41c4-a47f-aba800e74639 --><!-- end item 5149f06f-1023-431d-b1e5-aba800e745dd -->","topic":{"id":"1c1a5a3f-9b4d-5aca-b1c7-548672455692","topicId":"b0551c5c-9ab6-4db2-b8e5-27b98c6108ac","topicName":"Coeliac disease","slug":"coeliac-disease","lastRevised":"Last revised in May 2020","chapters":[{"id":"1ab49395-0a38-5106-ac8c-081d06df8957","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"42fe31c7-8b64-527e-bd5e-51c32714ee29","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"26b08904-13dc-5b32-8bc4-2549fa573fb3","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5c0dee49-ba90-52f3-a99a-676cb4ca5418","slug":"changes","fullItemName":"Changes"},{"id":"875d3bb9-e2eb-51af-b90b-a59a08a4c149","slug":"update","fullItemName":"Update"}]},{"id":"9ced2297-bd68-58b0-b12e-d660074f8e9e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"394005c9-726f-5f88-be40-717a7d0adb86","slug":"goals","fullItemName":"Goals"},{"id":"2f234477-2111-51de-8800-18b0231b7b5c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"82c4f886-1b62-5a2f-b956-e939a3736a77","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"352349eb-c34b-5c8a-8f35-cc52c1e427e0","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ba3abfa3-9c4f-527d-bc4a-30d501245cb7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"67796a49-6946-5a26-9be6-3d4e8ae58914","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"f7799373-9e95-51e7-beb7-1fecaaa38b46","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d877907c-0181-5747-953a-1057a01509ee","slug":"definition","fullItemName":"Definition"},{"id":"13d4bc73-968e-5163-b7b1-3a66b2f0e52c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f33b46df-e16f-5d24-a608-1b5b4a4b605a","slug":"causes","fullItemName":"Causes"},{"id":"09a61360-9601-5caa-84af-2136bd4a7603","slug":"complications","fullItemName":"Complications"},{"id":"9db3868a-f808-5034-8563-58a2c84ab545","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13e9616c-5ad7-54a8-af68-dad57366685f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"77ada14b-2c51-5bf2-894b-526f099ef23e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d056d742-1aa4-57bc-8e9b-3730a715a6dd","slug":"assessment","fullItemName":"Assessment"},{"id":"98e1c8e5-e970-57a5-a01e-0d4ad52bc8ca","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4561ec77-0c01-5346-8f45-78e225038140","fullItemName":"Management","slug":"management","subChapters":[{"id":"ee522102-0563-555f-a5b5-a9199c67b6a8","slug":"management-of-confirmed-coeliac-disease","fullItemName":"Scenario: Management of confirmed coeliac disease"}]},{"id":"e9edb239-af7b-54d7-ad64-dadf49939e27","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc5fb8ef-a4c4-581b-8828-fa524bfc69ca","slug":"gluten-free-products","fullItemName":"Gluten-free products"}]},{"id":"76c25337-4d0a-5036-b7cf-1c7ca39a7e48","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6001d4b8-f58d-5d70-a396-3f47044d6a24","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"cf74b6f9-a29b-5108-b99b-0d2d5782850a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"472110e6-ab58-582f-8614-7d056d174365","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4c098beb-df9b-5e8d-8fdf-0197b1dd54d3","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9a97c354-b836-5bab-8cbf-eb9d5698f9cb","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a79c40d9-503b-5914-bb11-f0370fa4119a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"aa655679-10e1-5946-87a1-3dfdf6ad91f3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"13e9616c-5ad7-54a8-af68-dad57366685f","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"def87066-018d-547d-a262-90364328b0cd","slug":"interpreting-serology-results","fullItemName":"Interpreting serology results","depth":3,"htmlHeader":"<!-- begin field d3aa2786-96e2-4303-9fc2-aba800e88b6e --><h3>Interpreting serology results</h3><!-- end field d3aa2786-96e2-4303-9fc2-aba800e88b6e -->","summary":null,"htmlStringContent":"<!-- begin item 955793b2-d6e7-4364-905e-aba800e88b3d --><!-- begin field 09b4c604-9ecd-49cb-a68a-aba800e88b6e --><p><strong>The diagnosis of coeliac disease usually relies on a combination of clinical, serological, and histopathological findings following duodenal biopsy </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>]<strong>. Be aware of the following when interpreting coeliac serology results.</strong></p><ul><li><strong>Equivocal serology test result.</strong><ul><li>For young people and adults, if the result of either immunoglobulin (Ig)A tissue transglutaminase antibody (tTGA) or IgA endomysial antibody (EMA) is equivocal, do the other test.</li><li>For children, if the result of either IgA tTGA or IgA EMA is equivocal, refer to a paediatric gastroenterologist for further investigation, which may include further serology testing, intestinal biopsy, human leukocyte antigen (HLA) genetic testing, or a combination of these.</li></ul></li><li><strong>Negative serology test result.</strong><ul><li>If the serology test (IgA tTGA or IgA EMA) is negative, check for IgA deficiency if this has not already been done.<ul><li>If IgA deficiency is present, this will cause a false-negative specific IgA test, so test for specific IgG instead (IgG tTGA, IgG EMA, or IgG deamidated gliadin peptide [DGP]), depending on local laboratory protocols.</li><li>Be aware that IgG antibody tests are not as specific as IgA antibody tests, and there should be a low threshold for referral.</li></ul></li><li>If the serology tests are truly negative (IgA tTGA is negative and IgA is normal), coeliac disease is unlikely. Advise the person that this excludes coeliac disease at present, but it does not rule out the possibility of disease developing in the future.</li><li>If a diagnosis of coeliac disease is strongly suspected, arrange referral for consideration of specialist tests even if serology is negative.</li></ul></li><li><strong>Positive serology test result.</strong><ul><li>Arrange referral for young people and adults to a gastroenterologist for specialist endoscopic intestinal biopsy to confirm or exclude the diagnosis.</li><li>Arrange referral for children to a paediatric gastroenterologist for further investigation to confirm or exclude the diagnosis. This may include further serology testing, intestinal biopsy, human leukocyte antigen (HLA) genetic testing, or a combination of these.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Caio, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Cichewicz, 2019</a>]</p><!-- end field 09b4c604-9ecd-49cb-a68a-aba800e88b6e --><!-- end item 955793b2-d6e7-4364-905e-aba800e88b3d -->","subChapters":[]},{"id":"24035297-6822-56a2-82f5-bed3e8a3d66c","slug":"basis-for-recommendation-e3d","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field d2b382fa-1665-4059-8864-aba800e74644 --><h3>Basis for recommendation</h3><!-- end field d2b382fa-1665-4059-8864-aba800e74644 -->","summary":null,"htmlStringContent":"<!-- begin item e3dd00c4-96ad-4217-8f6a-aba800e74644 --><!-- begin field 9134fecb-5999-4132-b7be-aba800e74644 --><p>The recommendations on assessment are largely based on the National Institute for Health and Care Excellence (NICE) clinical guideline <em>Coeliac disease: recognition, assessment and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>]; the joint British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and Coeliac UK publication <em>Guidelines for the diagnosis and management of coeliac disease in children</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>]; the British Society of Gastroenterology (BSG) guidelines <em>Diagnosis and management of adult coeliac disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>]; the European Society for the Study of Coeliac Disease (ESsCD) publication <em>Guideline for coeliac disease and other gluten-related disorders</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>]; the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) publication <em>Guidelines for Diagnosing Coeliac Disease 2020</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>]; the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) publication <em>Clinical report on the diagnosis and treatment of gluten-related disorders</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>]; the American Gastroenterological Association (AGA) clinical practice update <em>Diagnosis and monitoring of celiac disease: changing utility of serology and histologic measures: expert review</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>]; a Prague consensus document <em>Transition from childhood to adulthood in coeliac disease</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2016</a>]; US best practice guidelines on coeliac disease in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Synder, 2016</a>]; and expert opinion in review articles on coeliac disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Cichewicz, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>] and on coeliac disease in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Thomas, 2018</a>].</p><h4>Clinical features on history taking</h4><ul><li>These recommendations are extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>], the BSG guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], the BSPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>], the ESPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>], the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Lebwohl, 2015</a>].</li></ul><h4>Clinical features on examination</h4><ul><li>The recommendations on abdominal examination and checking body mass index (BMI) are extrapolated from the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>], a Prague consensus document [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2016</a>], and US best practice guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Synder, 2016</a>].</li><li>The recommendation on assessing for dermatitis herpetiformis is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>], the BSPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>], the BSG guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], and the ESsCD publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].<ul><li>The information that less than 10% of people with dermatitis herpetiformis have symptoms or signs of malabsorption is based on the BSG guidelines.</li></ul></li></ul><h4>Arranging coeliac serology testing</h4><ul><li>The recommendation that a person must be eating a gluten-containing diet before coeliac serology testing is based on the NICE clinical guideline, which advised this is needed for a minimum of 6 weeks in order to maximize the accuracy of serological testing and avoid false-negative results [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>].<ul><li>This approach is supported by the BSPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>], the ESsCD publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>], the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], and the AGA clinical practice update [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li></ul></li><li>The recommendation to check serum immunoglobulin (Ig)A tissue transglutaminase antibody (tTGA) and total IgA first-line is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>] and the ESPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>].<ul><li>If coeliac disease is suspected, measurement of IgA tTGA has superior assay accuracy compared with other coeliac antibody combinations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>].</li><li>This approach is supported by the NASPGHAN publication that notes that IgA tTGA is the most cost-effective and reliable test to identify people with coeliac disease, as it is highly sensitive and specific [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>]. The ESsCD publication states it has a sensitivity and specificity of about 95%, and the higher the titre, the greater the likelihood of a true positive result [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].</li><li>Expert opinion in a review article also notes it is the preferred first-line test owing to its high sensitivity and negative predictive value [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>].</li></ul></li><li>The recommendation to check serum total IgA levels concurrently is based on the fact IgA deficiency may lead to a false-negative test result [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>].<ul><li>The ESsCD publication notes that IgA deficiency affects 2–3% of people with coeliac disease [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].</li></ul></li><li>The recommendation to check serum IgA endomysial antibody (EMA) second-line is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>].<ul><li>NICE notes that this approach has high specificity and only slightly reduced sensitivity.</li><li>This is supported by the ESsCD publication, which notes that IgA EMA may be used as a confirmatory test, particularly when tTGA has a low titre [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>]. This is further supported by the AGA clinical practice update, which states that IgA EMA is well suited for second-line confirmatory testing, as EMA has a high specificity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li></ul></li><li>The recommendation to check serum IgG coeliac antibody levels if there is IgA deficiency is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>] and the AGA clinical practice update [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li><li>The recommendation not to perform human leukocyte antigen (HLA) genetic testing in primary care is based on the NICE clinical guideline, which states not to use these tests in the initial diagnosis of coeliac disease in non-specialist settings [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>]. This approach is supported by the BSG publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], the ESPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>], the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], the AGA clinical practice update [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>].<ul><li>HLA testing has a limited role in the diagnosis of coeliac disease, and its value is largely related to its negative predictive value to rule out coeliac disease in specific clinical situations, such as cases where there are equivocal histological findings and negative serology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>].</li></ul></li><li>The recommendation to consider coeliac serology re-testing if a person presents with new symptoms of coeliac disease is based on the clinical experience and expertise of the NICE guideline development group. This noted that people with risk factors for coeliac disease who test negative initially may remain at increased risk of developing the disease in the future, when seroconversion may happen [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>].</li></ul><h4>Arranging referral to a gastroenterologist</h4><ul><li>The recommendation to arrange gastroenterology referral to confirm the diagnosis is largely based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>], the BSG guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], the ESsCD publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>], the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>].<ul><li>The NICE guideline development group concluded that a biopsy should always be used to confirm the diagnosis as serology is not always reliable, there may be false positives if relying solely on serology results, intestinal biopsy allows for exclusion of co-morbid or alternative conditions, and initial biopsy provides a baseline for comparison if further biopsies are needed in the future. However, it recognized that biopsy may not always be available or appropriate for children.</li><li>The BSG guidelines note that duodenal biopsy remains essential for the diagnosis in adults to assess for histological changes suggestive of coeliac disease (increased intraepithelial lymphocytosis, crypt hyperplasia, and villous atrophy), and this cannot be replaced by serology. This is supported by expert opinion in a review article that notes that most people are diagnosed on the basis of positive coeliac serology followed by a confirmatory duodenal biopsy [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>].</li><li>The ESsCD publication highlights that the diagnosis of coeliac disease relies on a combination of clinical, serological, and histopathological findings. It notes that about one-third of newly diagnosed cases have a normal endoscopic appearance of the duodenum, therefore, biopsies should be taken even if this is the case.</li></ul></li><li>The BSPGHAN and ESPGHAN publications recommend that all children with suspected coeliac disease should have their diagnosis established by a paediatric gastroenterologist [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2020</a>].<ul><li>Children should not be started on a gluten-free diet on the basis of coeliac serology results alone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>].</li><li>The ESPGHAN publication states that a subgroup of children with high titres of IgA tTGA (more than 10 times the upper limit of normal), with detectable IgA EMA, HLA-DQ2/HLA-DQ8 positivity, and signs/symptoms suggestive of coeliac disease, may not need duodenal biopsy to confirm the diagnosis. This is because coeliac enteropathy is nearly invariably present in children with very high serum coeliac autoantibody levels.</li></ul></li><li>The recommendation to advise the person not to start a gluten-free diet until the diagnosis is confirmed by a specialist is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>]. This approach is supported by the BSG guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], the ESsCD publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>], the AGA clinical practice update [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>].<ul><li>Reduction or avoidance of gluten prior to diagnostic testing may reduce the sensitivity of biopsy testing [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li><li>People should remain on a gluten-containing diet until endoscopy because histological features may normalize on a gluten-free diet [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Mooney, 2014a</a>].</li></ul></li><li>The recommendation to arrange referral even if coeliac serology is negative is largely based on the clinical experience and expertise of the NICE guideline development group [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">NICE, 2015b</a>].<ul><li>The ESsCD publication also notes that IgA tTGA may be negative in 5–15% of people with biopsy-confirmed coeliac disease tested while on a gluten-containing diet [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Al-Toma, 2019</a>].</li><li>This approach is supported by the NASPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>], the BSPGHAN publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Murch, 2013</a>], the BSG guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Ludvigsson, 2014</a>], and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Cichewicz, 2019</a>].</li></ul></li><li>The AGA clinical practice update notes that where there is a strong suspicion of coeliac disease in people with positive serology but the biopsy is negative, repeat biopsies may be considered at the time of initial assessment or in the future [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Husby, 2019</a>].</li></ul><h4>Arranging referral to a dermatologist</h4><ul><li>This recommendation is based on the fact that a diagnosis of dermatitis herpetiformis is confirmed by skin biopsy with special stains that show typical IgA deposits in perilesional skin [<a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">Hill, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/coeliac-disease/references/\">McAllister, 2019</a>].</li></ul><!-- end field 9134fecb-5999-4132-b7be-aba800e74644 --><!-- end item e3dd00c4-96ad-4217-8f6a-aba800e74644 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}